Article
The Met pathway: master switch and drug target in cancer progression
27 Jul 2006
Abstract excerpt
It has been recognized for more than a century that most tumors tend to become more aggressive in clinical behavior over time, although this time course may be variable. This phenomenon has been termed "cancer progression," a process that appears to develop in a stepwise fashion through qualitatively different stages. Cancer progression relies on the ability of neoplastic cells to abandon their primary site of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.